Cite
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
MLA
Pankaj Chaturvedi, et al. “Nimotuzumab-Cisplatin-Radiation versus Cisplatin-Radiation in HPV Negative Oropharyngeal Cancer.” Oncotarget, vol. 11, Jan. 2020, pp. 399–408. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....50980a325cf80ca104f322c3e27efad3&authtype=sso&custid=ns315887.
APA
Pankaj Chaturvedi, Manish Kumar Pandey, Vijay Patil, Kumar Prabhash, Arun Chandrasekharan, Sudhir Nair, Usha Patel, Nilesh Sabale, Shivakumar Thiagarajan, Devendra Chaukar, Prathamesh S. Pai, Hollis Dsouza, Vanita Noronha, Atanu Bhattacharjee, Amit Joshi, Anil K. D’Cruz, Shripad Banavali, Ashwini Budrukkar, Manoj B. Mahimkar, … Sarbani Ghosh-Laskar. (2020). Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer. Oncotarget, 11, 399–408.
Chicago
Pankaj Chaturvedi, Manish Kumar Pandey, Vijay Patil, Kumar Prabhash, Arun Chandrasekharan, Sudhir Nair, Usha Patel, et al. 2020. “Nimotuzumab-Cisplatin-Radiation versus Cisplatin-Radiation in HPV Negative Oropharyngeal Cancer.” Oncotarget 11 (January): 399–408. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....50980a325cf80ca104f322c3e27efad3&authtype=sso&custid=ns315887.